➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: March 2, 2021

DrugPatentWatch Database Preview

Ecallantide - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for ecallantide

Tradenames:	1
Patents:	7
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for ecallantide

Recent Clinical Trials for ecallantide

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Mark Davis-Lorton, MD	Phase 2
Shire	Phase 2
Bernstein, Jonathan A., M.D.	Phase 2

See all ecallantide clinical trials

Pharmacology for ecallantide

Mechanism of Action	Kallikrein Inhibitors

Patent Text Search: US Patents for ecallantide

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Dyax Corp.	KALBITOR	ecallantide	INJECTABLE; INJECTION	125277	001	2009-12-01	Start Trial	Isis Pharmaceuticals, Inc. (Carlsbad, CA)	2031-06-10	RX	Orphan	search
Dyax Corp.	KALBITOR	ecallantide	INJECTABLE; INJECTION	125277	001	2009-12-01	Start Trial	Ionis Pharmaceuticals, Inc. (Carlsbad, CA)	2031-06-10	RX	Orphan	search
Dyax Corp.	KALBITOR	ecallantide	INJECTABLE; INJECTION	125277	001	2009-12-01	Start Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2033-03-11	RX	Orphan	search
Dyax Corp.	KALBITOR	ecallantide	INJECTABLE; INJECTION	125277	001	2009-12-01	Start Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2029-05-13	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for ecallantide

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2012170947	Start Trial
China	107206015	Start Trial
Australia	2015335618	Start Trial
European Patent Office	3209303	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck

Dow

Colorcon

Express Scripts

Harvard Business School

McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.